Colombo, Carla
4 papers on CoChatORCID 0000-0002-8975-695X
Most cited papers
- Verified
Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del CFTR
Wainwright, C. E., Elborn, J. S., Ramsey, B. W., Marigowda, G., Huang, X., Cipolli, M., Colombo, C., Davies, J. C., De Boeck, K., Flume, P. A., et al. (2015) · New England Journal of Medicine
Cystic Fibrosis Research AdvancesInhalation and Respiratory Drug Delivery
Cited by 1,622
- Verified
Long-term safety and efficacy of tezacaftor-ivacaftor in individuals with cystic fibrosis aged 12 years or older who are homozygous or heterozygous for Phe508del CFTR (EXTEND): an open-label extension study
Flume, P. A., Biner, R. F., Downey, D. G., Brown, C., Jain, M., Fischer, R., De Boeck, K., Sawicki, G. S., Chang, P., Paz-Diaz, H., et al. (2021) · The Lancet Respiratory Medicine
Cystic Fibrosis Research AdvancesInhalation and Respiratory Drug Delivery
Cited by 52
- Verified
Successful ceftazidime‐avibactam treatment of post‐surgery Burkholderia multivorans genomovar II bacteremia and brain abscesses in a young lung transplanted woman with cystic fibrosis
Daccò, V., Claut, L., Piconi, S., Castellazzi, L., Garbarino, F., Teri, A., & Colombo, C. (2019) · Transplant Infectious Disease
Burkholderia infections and melioidosisInfections and bacterial resistance
Cited by 28
- Verified
Change in nutrient and dietary intake in European children with cystic fibrosis after a 6-month intervention with a self-management mHealth tool
Calvo-Lerma, J., Boon, M., Hulst, J., Colombo, C., Asseiceira, I., Garriga, M., Masip, E., Claes, I., Bulfamante, A., Janssens, H. M., et al. (2021) · Nutrients
Mobile Health and mHealth ApplicationsCystic Fibrosis Research Advances
Cited by 14
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free